{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:25:20Z","timestamp":1760081120539,"version":"3.40.5"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"18","license":[{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5,3]]},"abstract":"<jats:p>Success in eradication of H. pylori is decreasing due to increasing resistant strains. In particular, side-effects due to 4-agent treatment multiple drug use are observed and treatment compliance decreases. The aim of this study was to evaluate the efficacy, reliability, and side-effect profile of the combination of amoxicillin and rabeprazole with gemifloxacin, which is a new generation quinolone, in the treatment of H. pylori infection. This study was conducted on 71 naive patients who received H. pylori eradication. All the patients were administered treatment of Amoxicillin (1000\u2009mg twice a day)\u2005+\u2005Gemifloxacin (320\u2009mg once a day)\u2005+\u2005rabeprazole (20\u2009mg twice a day) for 7 days. Drug compliance and treatment tolerance were evaluated after finishing the treatment. At 1 month after the end of the treatment, H. pylori eradication was evaluated in all the patients by examining H. pylori antigen in the feces. In the evaluation after treatment, H. pylori eradication was obtained in 63 (88.7%) patients and eradication was not obtained in 8 (11.3%) patients. The treatment was not completed by 2 patients because of side-effects and noncompliance, so after exclusion of these 2 patients, successful H. pylori eradication was obtained in 63 (91.3%) of 69 patients who completed the treatment. Side-effects were seen in a total of 9 (12.7%) patients. Diarrhea, bloating, abdominal pain, and nausea-vomiting were seen in some patients, but no reflux, constipation, skin rash, listlessness-fatigue, headache, dizziness, palpitations, dry mouth, or weight loss was seen in any patient. In regions with high resistance to clarithromycin and metronidazole in particular, the combination of gemifloxacin with amoxicillin and rabeprazole can be considered for use in first-stage treatment as both the efficacy and tolerability are high.<\/jats:p>","DOI":"10.1097\/md.0000000000038012","type":"journal-article","created":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T18:05:33Z","timestamp":1714759533000},"page":"e38012","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Amoxicillin, gemifloxacin and rabeprazole, as first-line Helicobacter pylori therapy in clinical practice: A pilot study"],"prefix":"10.1097","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6799-3391","authenticated-orcid":false,"given":"Guner","family":"Kilic","sequence":"first","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Division of Gastroenterology, Van, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulce Ecem","family":"Kilic","sequence":"additional","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Van, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"\u00d6zkahraman","sequence":"additional","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Van, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevki","family":"Konur","sequence":"additional","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Van, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramazan","family":"Dertli","sequence":"additional","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Division of Gastroenterology, Van, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuf","family":"Kayar","sequence":"additional","affiliation":[{"name":"Van Training and Research Hospital, Department of Internal Medicine, Division of Gastroenterology, Van, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration.","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/0140-6736(90)91301-P","article-title":"Cure of duodenal ulcer associated with eradication of Helicobacter pylori.","volume":"335","author":"Rauws","year":"1990","journal-title":"Lancet"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1053\/j.gastro.2007.11.009","article-title":"Host-bacterial interactions in Helicobacter pylori infection.","volume":"134","author":"Amieva","year":"2008","journal-title":"Gastroenterology"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"5283","DOI":"10.3748\/wjg.v20.i18.5283","article-title":"Treatment of Helicobacter pylori infection: current status and future concepts.","volume":"20","author":"Yang","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","article-title":"Management of Helicobacter pylori infection: the Maastricht VI\/Florence consensus report.","volume":"71","author":"Malfertheiner","year":"2022","journal-title":"Gut"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.3748\/wjg.v26.i15.1733","article-title":"Update on quinolone-containing rescue therapies for Helicobacter pylori infection.","volume":"26","author":"Mori","year":"2020","journal-title":"World J Gastroenterol"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis: the updated Sydney system.","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"8188","DOI":"10.3748\/wjg.v19.i45.8188","article-title":"Stool antigen tests for the management of Helicobacter pylori infection.","volume":"19","author":"Shimoyama","year":"2013","journal-title":"World J Gastroenterol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.4103\/jms.jms_25_17","article-title":"World health organization releases global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics.","volume":"32","author":"Shrivastava","year":"2018","journal-title":"J Med Soc"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/MCG.0b013e318030e3c3","article-title":"Helicobacter pylori infection and related gastrointestinal diseases.","volume":"41","author":"Makola","year":"2007","journal-title":"J Clin Gastroenterol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"Management of Helicobacter pylori infection\u2014the Maastricht IV\/Florence consensus report.","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrgastro.2010.210","article-title":"Optimal therapy for Helicobacter pylori infections.","volume":"8","author":"Rimbara","year":"2011","journal-title":"Nature Rev Gastroenterol Hepatol"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/ncpgasthep1138","article-title":"New concepts of resistance in the treatment of Helicobacter pylori infections.","volume":"5","author":"Graham","year":"2008","journal-title":"Nature Clin Pract Gastroenterol Hepatol"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.3748\/wjg.v20.i18.5205","article-title":"Culture-guided treatment approach for Helicobacter pylori infection: review of the literature.","volume":"20","author":"Cammarota","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.dld.2012.08.025","article-title":"Modified sequential therapy regimens for Helicobacter pylori eradication: a systematic review.","volume":"45","author":"Zullo","year":"2013","journal-title":"Digest liver dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.3390\/antibiotics10091058","article-title":"Antibiotic resistance prevalence and trends in patients infected with helicobacter pylori in the period 2013\u20132020: results of the European registry on H. pylori management (hp-Eureg).","volume":"10","author":"Bujanda","year":"2021","journal-title":"Antibiotics"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/hel.12272","article-title":"Prevalence of primary antimicrobial resistance of H. pylori in Turkey: a Systematic Review.","volume":"21","author":"Kocazeybek","year":"2016","journal-title":"Helicobacter"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/2050640620972615","article-title":"European registry on Helicobacter pylori management: single\u2010capsule bismuth quadruple therapy is effective in real\u2010world clinical practice.","volume":"9","author":"Nyssen","year":"2021","journal-title":"UEG Journal"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:04:46Z","timestamp":1746320686000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000038012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,3]]},"references-count":18,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000038012","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2024,5,3]]}}}